KERN

Akerna Corp. KERN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode KERN ATLN BLPH HSTO SEEL VIRI MSPR HUGE CMAX TCBP
6M -94.97 % 29.85 % -76.47 % -93.33 % -97.25 % -98.50 % -99.10 % -99.82 % 421 400.01 % -99.38 %
YTD -95.93 % 27.94 % 0.00 % -93.55 % -99.79 % -98.94 % -33.22 % -99.85 % 1 586.00 % -94.85 %
1Y -98.22 % -48.82 % -81.27 % -93.73 % -99.82 % -99.11 % -99.63 % -99.90 % 1 363.54 % -99.80 %
3Y -99.99 % -83.35 % -99.57 % -99.71 % -99.99 % -99.89 % -99.63 % -99.92 % -99.58 % -100.00 %
5Y -99.99 % -98.56 % -99.79 % -99.97 % -99.99 % -99.96 % -99.63 % -99.99 % -99.91 % -100.00 %
10Y -99.99 % -98.56 % -99.99 % -100.00 % -100.00 % -99.96 % -99.63 % -99.99 % -99.86 % -100.00 %
From the beginning -99.99 % -98.56 % -99.99 % -100.00 % -100.00 % -99.96 % -99.63 % -99.99 % -99.86 % -100.00 %

Dividend

Bellerophon Therapeutics, Inc.